Evidence map›Paper›PMID 42278928›Full record

ReviewJournal of clinical medicine2026

Xanthogranulomatous Inflammatory Pelvic Mass Mimicking Malignancy: Successful Conservative Treatment and Narrative Insights into Diagnosis and Management.

Carmine Siniscalchi, Augusto Vaglio, Alessandro Palumbo, Beatrice Prati, Antonio Nouvenne, Alberto Parise, Nicoletta Cerundolo, Domenico Corradi, Jean-Francois Emile, Claudio Tana and 1 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Carmine SiniscalchiInternal Medicine Department, Parma University Hospital, 43125 Parma, Italy.ORCID 0000-0002-0613-1074
Augusto VaglioDepartment of Biomedical, Experimental and Clinical Sciences, University of Florence, 50121 Florence, Italy.
Alessandro PalumboRadiology Department, Parma University Hospital, Via Gramsci 14, 43125 Parma, Italy.
Beatrice PratiInternal Medicine Department, Parma University Hospital, 43125 Parma, Italy.
Antonio NouvenneInternal Medicine Department, Parma University Hospital, 43125 Parma, Italy.ORCID 0000-0002-2680-2242
Alberto PariseInternal Medicine Department, Parma University Hospital, 43125 Parma, Italy.
Nicoletta CerundoloInternal Medicine Department, Parma University Hospital, 43125 Parma, Italy.ORCID 0009-0004-6724-4277
Domenico CorradiParma University Hospital, 43125 Parma, Italy.
Jean-Francois EmileUniversité Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Inserm U981, 91190 Boulogne-Billancourt, France.ORCID 0000-0002-6073-4466
Claudio TanaInternal Medicine Unit, Eastern Hospital of Taranto, 74024 Taranto, Italy.ORCID 0000-0002-9162-7866
Tiziana MeschiInternal Medicine Department, Parma University Hospital, 43125 Parma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pelvic xanthogranulomatous inflammation is a rare pathological entity that can closely mimic malignant disease on cross-sectional imaging, often leading to consideration of radical surgical intervention. We report the case of a 59-year-old woman who presented with a large retrovesical pelvic mass initially suspected to be a malignant process. A definitive diagnosis was established only after tissue biopsy and comprehensive histopathological examination, which excluded malignancy and demonstrated xanthogranulomatous histiocytic inflammation. In light of the lesion's anatomical location and the substantial morbidity associated with surgical resection, a conservative medical strategy was pursued. Treatment with systemic corticosteroids and everolimus led to marked clinical improvement and a substantial radiological response, with reduction in lesion size from 41 × 26 mm to 27 × 17 mm, thereby allowing avoidance of mutilating surgery. This case underscores the critical role of biopsy and expert pathological assessment in guiding clinical decision-making and supports the consideration of non-surgical therapeutic approaches in selected patients with xanthogranulomatous pelvic lesions.

Indexed as

conservative managementeverolimushistiocytic disordersIgG4-related diseasemTOR inhibitorspelvic massxanthogranulomatous inflammation

Identifiers

PMID42278928
PMCPMC13257413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.